- £767.55m
- £765.63m
- £20.27m
Syncona Limited - Freeline Shareholders Approve Acquisition
Brief: Syncona Qtrly Net Assets Of 188.2p/Share
Syncona Limited - Third Quarter Update
Brief: Syncona Notes Autolus Therapeutics' Initial Data From MCARTY Phase I Study
Freeline climbs on $28 mln buyout deal by Syncona
Brief: Syncona Ltd To Acquire Freeline Therapeutics
Brief: Syncona To Acquire Freeline Therapeutics
Syncona Limited - Syncona to acquire Freeline Therapeutics Holdings
Syncona Limited - Martin Murphy to step down as Chair of SIML
Syncona Limited - Half-year Report
Syncona Limited - Autolus reports Q3 2023 Financial Results
Syncona Limited - Notice of Results
Freeline rises on proposal for acquisition of all outstanding shares
Syncona Limited - Proposal to acquire Freeline Therapeutics
Brief: Syncona Says Anv419 Continues To Demonstrate Potentially Differentiated Safety Profile To Approved Il-2 Therapies
Brief: Syncona Launches Share Buyback Of Up To 40 Mln Stg
Syncona down on writing off 54.5 mln stg as Novartis ends Gyroscope's therapy
UK Stocks-Factors to watch on Sept 11 (updated)
UK's Syncona writes off 54.5 mln stg after Novartis ends Gyroscope's therapy